CD8A and pelvic inflammatory disease: In univariate analysis, a PID diagnosis, AUC0-100 of CD8+ cells, serotherapy with ATG, HSC source of peripheral blood and EBV seropositivity of HSCT recipient were significantly associated with increasing the risk of EBV reactivation.